Market
First major pharma partner for Oracle AI mRNA cancer vaccines by end of 2025?
3
Resolution / Starting Odds
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Official partnership announcements from Oracle or pharmaceutical companies
Story
Oracle CEO Larry Ellison Announces AI-Designed mRNA Cancer Vaccines in 48 Hours at White House, Calls AI Our Best Shot at a Cure
Jan 21, 2025, 11:29 PM
Larry Ellison, CEO of Oracle, announced at the White House that artificial intelligence (AI) will soon be capable of designing personalized mRNA vaccines for cancer patients within 48 hours. This initiative, part of a broader project referred to as Project Starship, aims to leverage AI for early cancer detection and the development of tailored vaccine therapies. Ellison emphasized the potential of AI to revolutionize healthcare, enabling faster drug discovery and personalized treatment options. He stated, "AI is our best shot at a cure," highlighting the importance of gene sequencing in the process of creating these vaccines. The announcement reflects a growing commitment to harnessing technology in the fight against cancer.
View original story
Similar markets
Pfizer • 25%
Moderna • 25%
BioNTech • 25%
Other • 25%
Oracle • 25%
Moderna • 25%
BioNTech • 25%
Other • 25%
Oracle • 25%
Pfizer • 25%
Moderna • 25%
Other • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Pfizer • 25%
Pfizer • 25%
Roche • 25%
Other • 25%
Novartis • 25%
